Log in to your Inderes Free account to see all free content on this page.
Aiforia Technologies
3.83
EUR
-2.05 %
AIFORIA
First North Finland
Medical Equipment & Services
Health Care
1,702 following
investors.aiforia.com
Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.
P/E (adj.) (24e)
-9.21
EV/EBIT (adj.) (24e)
-8.69
P/B (24e)
7.05
Dividend yield-% (24e)
-
Target price
4.60 EUR
Recommendation
Accumulate
Updated
2.10.2024
First North Finland
AIFORIA
Daily low / high price
3.62 / 4.06
EUR
Market cap
110.74M EUR
Turnover
69.39K EUR
Volume
18K
Business risk
Valuation risk
Current
Previous
Latest research
Extensive report
Inderes' extensive report is an investor's handbook on customer companies covered by our research.
The latest extensive report was released
Read the reportAnalyst
Antti Luiro
Head of Nordic ER Development, Analyst
Frans-Mikael Rostedt
Analyst
Latest videos
Financial calendar
Annual report
07.03.2025
General meeting
04.04.2025
Interim report
28.08.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Sto-Rahoitus Oy | 5.3 % | 5.3 % |
| Sijoitusrahasto Aktia Nordic Micro Cap | 4.6 % | 4.6 % |
Premium
This content is for our Premium customers only.
Insider Transactions
| Insider | Date | Total value |
|---|---|---|
| Johan Lundin | 12.11.2024 | 1,050,000EUR |
| Pekka Mattila | 20.09.2024 | 7,323EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.8 | 1.0 | 1.6 | 2.4 | 3.4 | 5.8 | 9.9 | 17.1 |
| growth-% | 32.9 % | 14.7 % | 64.9 % | 49.3 % | 41.2 % | 71.1 % | 71.1 % | 72.4 % |
| EBITDA | -1.6 | -3.5 | -9.5 | -9.7 | -8.2 | -7.0 | -3.7 | 2.5 |
| EBIT (adj.) | -2.6 | -4.7 | -11.8 | -12.9 | -12.1 | -11.8 | -9.9 | -3.9 |
| EBIT | -2.6 | -4.7 | -11.8 | -12.9 | -12.1 | -11.8 | -9.9 | -3.9 |
| Profit before taxes | -2.8 | -7.6 | -12.2 | -12.9 | -12.0 | -11.9 | -10.2 | -4.2 |
| Net income | -2.8 | -7.6 | -12.2 | -12.9 | -12.0 | -11.9 | -10.2 | -4.2 |
| EPS (adj.) | -0.14 | -0.29 | -0.47 | -0.50 | -0.42 | -0.41 | -0.35 | -0.15 |
| growth-% | ||||||||
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| EBITDA-% | -189.8 % | -354.2 % | -593.3 % | -404.5 % | -241.9 % | -120.5 % | -36.9 % | 14.6 % |
| EBIT-% (adj.) | -310.1 % | -481.4 % | -731.9 % | -537.1 % | -358.4 % | -204.4 % | -100.0 % | -22.9 % |
| EBIT-% | -310.1 % | -481.4 % | -731.9 % | -537.1 % | -358.4 % | -204.4 % | -100.0 % | -22.9 % |
| ROE | -386.3 % | -39.0 % | -36.2 % | -54.8 % | -71.4 % | -123.5 % | 724.2 % | 48.9 % |
| ROI | -77.0 % | -20.9 % | -31.8 % | -45.4 % | -51.3 % | -56.0 % | -54.6 % | -23.0 % |
Login required
This content is only available for logged in users
Valuation
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 5.01 | 5.22 | 3.23 | 3.49 | 3.83 | 3.83 | 3.83 | 3.83 |
| Shares | 20.0 | 25.8 | 25.8 | 26.0 | 28.8 | 28.8 | 28.8 | 28.9 |
| Market cap | 100.1 | 134.6 | 83.4 | 90.6 | 110.3 | 110.3 | 110.4 | 110.6 |
| Enterprise value | 101.4 | 99.4 | 62.4 | 82.4 | 105.4 | 117.3 | 126.5 | 129.9 |
| EV/S | 119.4 | 102.0 | 38.9 | 34.4 | 31.1 | 20.3 | 12.8 | 7.6 |
| EV/EBITDA | - | - | - | - | - | - | - | 52.2 |
| EV/EBIT (adj.) | - | - | - | - | - | - | - | - |
| EV/EBIT | - | - | - | - | - | - | - | - |
| P/E (adj.) | - | - | - | - | - | - | - | - |
| P/E | - | - | - | - | - | - | - | - |
| P/B | 112.9 | 3.5 | 2.8 | 5.1 | 7.1 | 29.8 | - | - |
| P/S | 117.9 | 138.2 | 51.9 | 37.8 | 32.6 | 19.0 | 11.1 | 6.5 |
| Dividend yield | ||||||||
| Equity ratio | 16.8 % | 86.4 % | 80.3 % | 63.5 % | 55.0 % | 15.0 % | -26.6 % | -41.9 % |
| Gearing ratio | 146.0 % | -92.8 % | -71.6 % | -45.4 % | -31.1 % | 191.1 % | -246.5 % | -179.5 % |
Login required
This content is only available for logged in users
Quarter data
| Q3/23 | Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24e | Q4/24e | 2024e | Q1/25e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4 | 2.4 | 1.4 | 2.0 | 3.4 | ||||
| EBITDA | -4.7 | -9.7 | -4.2 | -4.0 | -8.2 | ||||
| EBIT | -6.5 | -12.9 | -6.1 | -6.1 | -12.1 | ||||
| Profit before taxes | -6.4 | -12.9 | -6.0 | -6.0 | -12.0 | ||||
| Net income | -6.4 | -12.9 | -6.0 | -6.0 | -12.0 |
Login required
This content is only available for logged in users
ShowingAll content types
Aiforia enters into new partnership to offer competitor's image analysis models on its own platform
Aiforia and Paige form strategic partnership to advance AI integration in pathology laboratories
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio